【Whitepaper】Azetidines in Drug Discovery

IF YOU DON'T SEE THIS EMAIL CORRECTLY, CLICK HERE

PharmaBlock Sciences (Nanjing), Inc. +86 400 025 5188 sales_china@pharmablock.com
PharmaBlock (USA), Inc. +1 – 877 878 5226/ 408 735 7571 salesusa@pharmablock.com

Company Website
Product Search

PharmaBlock Whitepaper
Bridging molecules for innovative medicines

Azetidines are good compromise between a satisfactory stability and a strong molecular rigidity, allowing an efficient tuning of pharmacological properties displayed by molecules bearing this moiety. Therefore, azetidine is considered a privileged scaffold in drug discovery.

A privileged scaffold in drug discovery

Providing an efficient tuning of pharmacological properties

Download the whitepaper

PharmaBlock Products - Azetidines
80,000+ building blocks, 63 series cover almost all the small molecule drugs R&D need

PB00072
CAS：36476-78-5

PB00460-01
CAS：100202-39-9

PB00224-01
CAS：18621-18-6

PB00233-1
CAS：617718-46-4

PB00004-01
CAS：217806-26-3

PB00226-01
CAS：148644-09-1

PB00435
CAS：142253-55-2

PB00438
CAS：610791-05-4

PB00001
CAS：141699-55-0

PB00447
CAS：142253-54-1

PB00430
CAS：254454-54-1

PB00003
CAS：398489-26-4

PB00441
CAS：142253-56-3

PB00141
CAS：325775-44-8

PB05848
CAS：1002355-96-5

PBZ4357-1
CAS：935669-67-3

PB03036
CAS：228857-58-7

PB03035
CAS：51077-14-6

PB00005-1
CAS：288315-03-7

PBN20121218-01
CAS：1427379-42-7

PB01226
CAS：124668-46-8

PBN2011006
CAS：1126650-67-6

PBN20120069
CAS：1126650-66-5

PB03881-01
CAS：943060-59-1

PB00436
CAS：36476-87-6

PB00236
CAS：18621-17-5

PB00448
CAS：36476-86-5

PBLL1506
CAS：138876-39-8

PBLLA099
CAS：164906-64-3

PBLL1105
CAS：40320-63-6




For product and service inquiries, please contact:
China & India Tel: +86-400 025 5188 Fax: +86-25 8691 8232 E-mail: sales_china@pharmablock.com	US & Europe PA Tel: +1-877 878 5226 / 267 649 7271 CA Tel: +1-408 735 7571 / 408 921 9969 E-mail: salesusa@pharmablock.com	Other Countries Tel: +86-25 8691 8086 / 8691 8288 Fax: +86-25 8691 8232 E-mail: sales@pharmablock.com

You're receiving this email because you have opted in the PharmaBlock mailing list. If you no longer wish to receive messages from us, please click here to unsubscribe.